Zobrazeno 1 - 4
of 4
pro vyhledávání: '"K H, Murthy"'
Autor:
S S, Abdel-Meguid, B W, Metcalf, T J, Carr, P, Demarsh, R L, DesJarlais, S, Fisher, D W, Green, L, Ivanoff, D M, Lambert, K H, Murthy
Publikováno v:
Biochemistry. 33(39)
(2R,4S,5S,1'S)-2-Phenylmethyl-4-hydroxy-5-(tert-butoxycarbonyl) amino-6-phenylhexanoyl-N-(1'-imidazo-2-yl)-2'-methylpropanamide (compound 2) is a tripeptide analogue inhibitor of HIV-1 protease in which a C-terminal imidazole substituent constitutes
Autor:
S K, Thompson, K H, Murthy, B, Zhao, E, Winborne, D W, Green, S M, Fisher, R L, DesJarlais, T A, Tomaszek, T D, Meek, J G, Gleason
Publikováno v:
Journal of medicinal chemistry. 37(19)
The rational design and synthesis of a highly potent inhibitor of HIV-1 protease have been accomplished. The inhibitor, SB 206343, is based on a model derived from the structure of the MVT-101/HIV-1 protease complex and contains a 4(5)-acylimidazole
Autor:
S S, Abdel-Meguid, B, Zhao, K H, Murthy, E, Winborne, J K, Choi, R L, DesJarlais, M D, Minnich, J S, Culp, C, Debouck, T A, Tomaszek
Publikováno v:
Biochemistry. 32(31)
The human immunodeficiency virus type 1 (HIV-1) protease is a potential target of acquired immune deficiency syndrome (AIDS) therapy. A highly potent, perfectly symmetrical phosphinate inhibitor of this enzyme, SB204144, has been synthesized. It is a
Publikováno v:
The Journal of biological chemistry. 267(32)
As part of a structure-based drug design program directed against enzyme targets in the human immunodeficiency virus (HIV), we have determined the three-dimensional structures of the HIV type 1 protease complexed with two hydroxyethylene-based inhibi